- Home
- CCCC vs CHPG Comparison
CCCC vs CHPG Comparison
Compare CCCC & CHPG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CCCC
- CHPG
- Stock Information
- Founded
- CCCC 2015
- CHPG 2024
- Country
- CCCC United States
- CHPG United States
- Employees
- CCCC N/A
- CHPG N/A
- Industry
- CCCC Biotechnology: Pharmaceutical Preparations
- CHPG
- Sector
- CCCC Health Care
- CHPG
- Exchange
- CCCC Nasdaq
- CHPG Nasdaq
- Market Cap
- CCCC 104.4M
- CHPG 100.3M
- IPO Year
- CCCC 2020
- CHPG N/A
- Fundamental
- Price
- CCCC $2.46
- CHPG $10.04
- Analyst Decision
- CCCC Buy
- CHPG
- Analyst Count
- CCCC 2
- CHPG 0
- Target Price
- CCCC $8.00
- CHPG N/A
- AVG Volume (30 Days)
- CCCC 1.5M
- CHPG 7.3K
- Earning Date
- CCCC 08-07-2025
- CHPG 07-23-2025
- Dividend Yield
- CCCC N/A
- CHPG N/A
- EPS Growth
- CCCC N/A
- CHPG N/A
- EPS
- CCCC N/A
- CHPG N/A
- Revenue
- CCCC $34,240,000.00
- CHPG N/A
- Revenue This Year
- CCCC N/A
- CHPG N/A
- Revenue Next Year
- CCCC N/A
- CHPG N/A
- P/E Ratio
- CCCC N/A
- CHPG N/A
- Revenue Growth
- CCCC 16.55
- CHPG N/A
- 52 Week Low
- CCCC $1.09
- CHPG $9.81
- 52 Week High
- CCCC $7.22
- CHPG $10.24
- Technical
- Relative Strength Index (RSI)
- CCCC 59.48
- CHPG N/A
- Support Level
- CCCC $1.95
- CHPG N/A
- Resistance Level
- CCCC $2.94
- CHPG N/A
- Average True Range (ATR)
- CCCC 0.26
- CHPG 0.00
- MACD
- CCCC 0.00
- CHPG 0.00
- Stochastic Oscillator
- CCCC 51.52
- CHPG 0.00
About CCCC C4 Therapeutics Inc.
C4 Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to delivering on the promise of targeted protein degradation science to create a new generation of medicines that transforms patients' lives. The Company is progressing targeted oncology programs through clinical studies and leveraging its TORPEDO platform to efficiently design and optimize small-molecule medicines to address difficult-to-treat diseases. Its degrader medicines are designed to harness the body's natural protein recycling system to rapidly degrade disease-causing proteins, offering the potential to overcome drug resistance, and drug undruggable targets and improve patient outcomes. Its pipeline is Cemsidomide, CFT1946, and CFT8919.
About CHPG ChampionsGate Acquisition Corporation Class A Ordinary Share
Championsgate Acquisition Corp is a blank check company.